Insider Transactions in Q4 2025 at Data Knights Acquisition Corp. (DKDCW)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 26
2025
|
Kenneth Alleyne Director |
BUY
Grant, award, or other acquisition
|
Direct |
38,219
+50.0%
|
-
|
|
Nov 26
2025
|
Eric Casaburi Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+28.94%
|
-
|
|
Nov 26
2025
|
Andrew B Zeinfeld Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+10.55%
|
-
|
|
Nov 26
2025
|
Jair Clarke Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+24.53%
|
-
|
|
Nov 26
2025
|
Thomas Kosasa Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+0.28%
|
-
|
|
Nov 26
2025
|
Sherry Coonse Mc Craw Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+44.4%
|
-
|
|
Nov 26
2025
|
Aaron Green Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+2.28%
|
-
|
|
Nov 26
2025
|
Robert Lawrence Golden Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+7.59%
|
-
|
|
Nov 26
2025
|
Jeffrey Yu Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+0.61%
|
-
|
|
Nov 24
2025
|
Aaron Green Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,000,000
+34.66%
|
-
|
|
Nov 24
2025
|
Robert Lawrence Golden Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
333,333
+22.6%
|
-
|
|
Nov 24
2025
|
Jeffrey Yu Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+2.67%
|
-
|
|
Nov 18
2025
|
Aaron Green Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
61,555
-3.3%
|
$61,555
$1.2 P/Share
|
|
Oct 22
2025
|
Aaron Green Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
64,767
-3.36%
|
$129,534
$2.23 P/Share
|
|
Oct 15
2025
|
Eric Casaburi Director |
BUY
Open market or private purchase
|
Direct |
10,000
+13.25%
|
$30,000
$3.05 P/Share
|